Matthew Singleton, Director at Viking Therapeutics, holds 9.50K shares in Viking Therapeutics (Ticker: VKTX), holds 4.97K shares in Cubist Pharma (Ticker: CBST). Most recently, Matthew Singleton Bought ― shares of Viking Therapeutics on May 31, 2018 for an estimated value of 93.19K.